Evidence map›Paper›PMID 25339682›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2014

Effects of chronic kidney disease on liver transport: quantitative intravital microscopy of fluorescein transport in the rat liver.

Jennifer C Ryan, Kenneth W Dunn, Brian S Decker

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.Drug metabolism and disposition: the biological fate of chemicals · 2018
    Article
  6. Article
  7. Biomedical optics express · 2017
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jennifer C RyanDivision of Nephrology, School of Medicine, Indiana University, Indianapolis, Indiana; and Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana.
Kenneth W DunnDivision of Nephrology, School of Medicine, Indiana University, Indianapolis, Indiana; and Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana.
Brian S DeckerDivision of Nephrology, School of Medicine, Indiana University, Indianapolis, Indiana; and Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana bsdecker@iu.edu.
Indiana University – Purdue University Indianapolis · US

Funding

NCATS NIH HHS TR000006PHS HHS 1K23KD084260-01A1
6 · The paper itself

Abstract

Clinical studies indicate that hepatic drug transport may be altered in chronic kidney disease (CKD). Uremic solutes associated with CKD have been found to alter the expression and/or activity of hepatocyte transporters in experimental animals and in cultured cells. However, given the complexity and adaptability of hepatic transport, it is not clear whether these changes translate into significant alterations in hepatic transport in vivo. To directly measure the effect of CKD on hepatocyte transport in vivo, we conducted quantitative intravital microscopy of transport of the fluorescent organic anion fluorescein in the livers of rats following 5/6th nephrectomy, an established model of CKD. Our quantitative analysis of fluorescein transport showed that the rate of hepatocyte uptake was reduced by ∼20% in 5/6th nephrectomized rats, consistent with previous observations of Oatp downregulation. However, the overall rate of transport into bile canaliculi was unaffected, suggesting compensatory changes in Mrp2-mediated secretion. Our study suggests that uremia resulting from 5/6th nephrectomy does not significantly impact the overall hepatic clearance of an Oatp substrate.

Indexed as

AnimalsATP-Binding Cassette TransportersBile DuctsBiological TransportDisease Models, AnimalDown-RegulationFluoresceinFluorescent DyesHepatocytesInjectionsLiverMaleMicroscopy, Fluorescence, MultiphotonNephrectomyOrganic Anion TransportersRats, Sprague-DawleyAbcc2 protein, ratATP-Binding Cassette TransportersFluoresceinFluorescent DyesOrganic Anion Transporterschronic kidney diseasecytochrome P-450hepatic transportMrp2Oatpsodium fluoresceinuremia

Identifiers

PMID25339682
PMCPMC4269673
OpenAlexW2077434024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.